Breakdown of self-tolerance in anergic B lymphocytes.

PubWeight™: 1.87‹?› | Rank: Top 3%

🔗 View Article (PMID 1830923)

Published in Nature on August 08, 1991

Authors

C C Goodnow1, R Brink, E Adams

Author Affiliations

1: Centenary Institute for Cancer Medicine and Cell Biology, University of Sydney, New South Wales, Australia.

Articles citing this

Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood (2010) 3.52

Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science (2014) 2.95

Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A (1996) 2.34

Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med (1994) 2.23

Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15

B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol (2007) 2.08

Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance. Proc Natl Acad Sci U S A (2009) 1.93

Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A (2009) 1.91

B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J Exp Med (2003) 1.89

Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med (2008) 1.88

The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. PLoS Biol (2008) 1.79

A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J Exp Med (1996) 1.58

Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cells. EMBO J (1993) 1.34

Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33

Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. Immunity (2011) 1.27

Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy. Immunity (2009) 1.23

Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci U S A (1994) 1.11

Antigen-stimulated dissociation of BCR mIg from Ig-alpha/Ig-beta: implications for receptor desensitization. Immunity (1999) 1.10

Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo. J Exp Med (1994) 1.10

Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10. J Immunol (2013) 1.10

Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM. J Immunol (2011) 1.08

Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells. Proc Natl Acad Sci U S A (2009) 1.06

Entry of B cell receptor into signaling domains is inhibited in tolerant B cells. J Exp Med (2000) 1.04

A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. EMBO J (1994) 1.02

Loss of the proapoptotic protein, Bim, breaks B cell anergy. J Exp Med (2006) 1.01

The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy. Haematologica (2014) 1.00

The riddle of the dual expression of IgM and IgD. Immunology (2006) 0.99

Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells. Mol Immunol (2009) 0.99

Persistence of peptide-induced CD4+ T cell anergy in vitro. J Exp Med (1998) 0.96

B cells in autoimmune diabetes. Rev Diabet Stud (2005) 0.93

Virus-induced maturation and activation of autoreactive memory B cells. J Exp Med (2000) 0.90

Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells. J Exp Med (2016) 0.90

Functional silencing is initiated and maintained in immature anti-insulin B cells. J Immunol (2009) 0.89

Targeting the B7 family of co-stimulatory molecules: successes and challenges. BioDrugs (2013) 0.89

Models of signal transduction through the B-cell antigen receptor. Immunology (2003) 0.87

Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG. Proc Natl Acad Sci U S A (1997) 0.86

Clonal redemption of autoantibodies by somatic hypermutation away from self-reactivity during human immunization. J Exp Med (2016) 0.86

Liver-expressed Igkappa superantigen induces tolerance of polyclonal B cells by clonal deletion not kappa to lambda receptor editing. J Exp Med (2011) 0.85

T cell-independent rescue of B lymphocytes from peripheral immune tolerance. Science (2000) 0.84

Receptors, subcellular compartments and the regulation of peripheral B cell responses: the illuminating state of anergy. Mol Immunol (2010) 0.84

Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes. BMC Immunol (2002) 0.84

Retention of anergy and inhibition of antibody responses during acute γ herpesvirus 68 infection. J Immunol (2012) 0.83

Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization. PLoS One (2015) 0.81

Autologous anti-idiotypic antibody response is regulated by the level of circulating complementary idiotype. Immunology (1996) 0.80

Historical overview of immunological tolerance. Cold Spring Harb Perspect Biol (2012) 0.79

B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens. J Autoimmun (2015) 0.78

Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1992) 0.77

Suppression of anti-erythrocyte autoantibody-producing B cells by a physiological IgG-anti-F(ab')2 antibody and escape from suppression by tumour transformation; a model relevant for the pathogenesis of autoimmune haemolytic anaemia. Clin Exp Immunol (1993) 0.76

Establishing anergy as a bona fide in vivo mechanism of B cell tolerance. J Immunol (2009) 0.76

Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies. Immunol Rev (2017) 0.76

Receptor editing: how B cells stay tolerant. J Exp Med (2007) 0.75

Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target. Br J Cancer (1998) 0.75

IgD attenuates the IgM-induced anergy response in transitional and mature B cells. Nat Commun (2016) 0.75

Articles by these authors

Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (1991) 4.04

Metabolism of proline and the hydroxyprolines. Annu Rev Biochem (1980) 2.91

Mapping quantitative trait loci for murine growth: a closer look at genetic architecture. Genet Res (1999) 2.27

Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev (1996) 1.77

Reproduction of radiologic images on plain paper. Radiographics (1998) 1.65

Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J Immunol (2000) 1.55

Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab (2001) 1.52

Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells. Int J Cancer (1975) 1.48

The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance. Immunol Rev (2001) 1.40

Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33

Sequence and immunogenicity of the 70-kDa heat shock protein of Mycobacterium leprae. J Immunol (1991) 1.31

Coenzyme content of purified alanine racemase from Pseudomonas. Biochem Biophys Res Commun (1969) 1.30

Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J Immunol (1998) 1.26

Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970. Lancet (1971) 1.25

Metabolism of proline and of hydroxyproline. Int Rev Connect Tissue Res (1970) 1.23

Self tolerance in the B-cell repertoire. Immunol Rev (1991) 1.22

Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs. Cell Death Differ (2010) 1.20

Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand. J Pharm Biomed Anal (2004) 1.19

D-lysine catabolic pathway in Pseudomonas putida: interrelations with L-lysine catabolism. J Bacteriol (1974) 1.19

Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids. Infect Immun (1989) 1.16

The impact of illness and the impact of school closure on social contact patterns. Health Technol Assess (2010) 1.15

The need for central and peripheral tolerance in the B cell repertoire. Science (1990) 1.12

Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci U S A (1994) 1.11

Fluorometric determination of pyridoxal phosphate in enzymes. Methods Enzymol (1979) 1.07

Invertebrate collagens. Science (1978) 1.07

Inducible degradation of hydroxyproline in Pseudomonas putida: pathway regulation and hydroxyproline uptake. J Bacteriol (1969) 1.06

Conservative management of pelvic organ prolapse in women. Cochrane Database Syst Rev (2006) 1.06

T cell receptor-triggered activation of intraepithelial lymphocytes in vitro. Int Immunol (1993) 1.04

Investigation of vancomycin and related substances by liquid chromatography/ion trap mass spectrometry. Rapid Commun Mass Spectrom (2006) 1.01

Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera. Int J Cancer (1976) 1.00

Expression of murine IL-12 is regulated by translational control of the p35 subunit. J Immunol (1999) 1.00

Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J Immunol (1998) 0.99

Group interpersonal psychotherapy for postnatal depression: a pilot study. Arch Womens Ment Health (2005) 0.98

Partial reaction of prolyl hydroxylase. (Gly-PRO-Ala)n stimulates alpha-ketoglutarate decarboxylation without prolyl hydroxylation. J Biol Chem (1978) 0.98

Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization. Gynecol Oncol (1989) 0.97

Nelson's syndrome. Eur J Endocrinol (2010) 0.97

Alpha-ketoglutaric semialdehyde dehydrogenase of Pseudomonas. Properties of the purified enzyme induced by hydroxyproline and of the glucarate-induced and constitutive enzymes. J Biol Chem (1967) 0.97

Over-expression of a gibberellin 2-oxidase gene from Phaseolus coccineus L. enhances gibberellin inactivation and induces dwarfism in Solanum species. Plant Cell Rep (2007) 0.95

Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. J Clin Lab Immunol (1980) 0.95

Controlled release of chlorhexidine from amorphous microporous silica. J Control Release (2009) 0.95

Complete structural characterisation of the mammalian and Drosophila TRAF genes: implications for TRAF evolution and the role of RING finger splice variants. Mol Immunol (2001) 0.94

Catalytic aspects of enzymatic racemization. Adv Enzymol Relat Areas Mol Biol (1976) 0.94

Long-term toxicity study of mycophenolic acid in rabbits. Toxicol Appl Pharmacol (1975) 0.94

Kinetic and structural studies of hydroxyproline 2-epimerase. J Biol Chem (1970) 0.93

Fluorometric determination of pyridoxal phosphate in enzymes. Anal Biochem (1969) 0.93

Non-contact ultra-widefield imaging of retinopathy of prematurity using the Optos dual wavelength scanning laser ophthalmoscope. Eye (Lond) (2013) 0.93

Sequence position of 3-hydroxyproline in basement membrane collagen. Isolation of glycyl-3-hydroxyprolyl-4-hydroxyproline from swine kidney. J Biol Chem (1975) 0.92

Human antigen-specific IgA responses in blood and secondary lymphoid tissue: an analysis of help and suppression. J Immunol (1984) 0.91

Supplementary water for breast-fed babies in a hot and dry climate--not really a necessity. Arch Dis Child (1983) 0.91

Glutarate semialdehyde dehydrogenase of Pseudomonas. Purification, properties, and relation to L-lysine catabolism. J Biol Chem (1977) 0.90

Calcific constructive pericarditis: a rare complication of CREST syndrome. Arthritis Rheum (1996) 0.90

Antibody-dependent cell-mediated cytotoxicity against melanoma cells induced by plasmapheresis. Lancet (1976) 0.90

Improved reversed-phase liquid chromatographic method combined with pulsed electrochemical detection for the analysis of amikacin. J Pharm Biomed Anal (2006) 0.90

Studies in gram staining. Stain Technol (1975) 0.90

Glycylhydroxyprolyl sequences in earthworm cuticle collagen: glycylhydroxyprolylserine. J Biol Chem (1970) 0.88

Properties of the inducible hydroxyproline transport system of Pseudomonas putida. J Bacteriol (1970) 0.88

Hormone secretion by human somatotrophic, lactotrophic, and mixed pituitary adenomas in culture. J Clin Endocrinol Metab (1979) 0.88

Bromocriptine inhibits prolactin and growth-hormone release by human pituitary tumours in culture. Lancet (1977) 0.87

Induction of separate catabolic pathways for L- and D-lysine in Pseudomonas putida. Biochem Biophys Res Commun (1971) 0.87

Leukocyte-dependent antibody in sheep immunized with murine mastocytoma cells. Eur J Immunol (1975) 0.87

Isolation and identification of 2,5-dioxovalerate, an intermediate in the bacterial oxidation of hydroxyproline. J Biol Chem (1965) 0.86

Physical exam and occult post-traumatic vascular lesions: implications for the evaluation and management of arterial injuries in modern warfare in the endovascular era. J Cardiovasc Surg (Torino) (2007) 0.86

Head-and-neck IMRT treatments assessed with a Monte Carlo dose calculation engine. Phys Med Biol (2005) 0.86

Evaluating social and behavioural impacts of English smoke-free legislation in different ethnic and age groups: implications for reducing smoking-related health inequalities. Tob Control (2010) 0.85

Enzymatic deamination of delta-1-pyrroline-4-hydroxy-2-carboxylate to 2,5-dioxovalerate (alpha-ketoglutaric semialdehyde). J Biol Chem (1965) 0.85

Nurse midwives' attitudes toward abortion performance and related procedures. J Nurse Midwifery (1995) 0.85

Factors influencing growth on L-lysine by Pseudomonas. Regulation of terminal enzymes in the delta-aminovalerate pathway and growth stimulation by alpha ketoglutarate. J Biol Chem (1977) 0.85

Impact evaluation of the "not me, not now" abstinence-oriented, adolescent pregnancy prevention communications program, Monroe County, New York. J Health Commun (2001) 0.84

Alpha-ketoglutaric semialdehyde dehydrogenase of Pseudomonas. Properties of the separately induced isoenzymes. J Biol Chem (1974) 0.84

Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation. Blood (1998) 0.84

Development of a liquid chromatographic assay for an anti-HIV tablet containing lamivudine, zidovudine and TMC278.HCL. J Pharm Biomed Anal (2008) 0.84

The immune response to mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis. J Neuroimmunol (1996) 0.83

The antibacterial action of crystal violet. J Pharm Pharmacol (1967) 0.83

Collagen helix stabilization by hydroxyproline in (Ala-Hyp-Gly)n. Biochem Biophys Res Commun (1979) 0.83

Negative impact of occupational exposure on surgical outcome in patients with rhinosinusitis. Allergy (2012) 0.83

Conservative management of pelvic organ prolapse in women. Cochrane Database Syst Rev (2004) 0.83

Does mechanical insult to cartilage trigger relapsing polychondritis? Scand J Rheumatol (2001) 0.82

Cellular mechanisms of self-tolerance. Curr Opin Immunol (1989) 0.82

The modulating effects of lymph on the synthesis of immunoglobulins by lymphoblasts. Cell Immunol (1977) 0.82

Basement membrane and interstitial collagen content of whole animals and tissues. Biochem Biophys Res Commun (1975) 0.82

Secretion of LH, FSH, and PRL shown by cell culture and immunocytochemistry of human functionless pituitary adenomas. Clin Endocrinol (Oxf) (1981) 0.81

Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study. Clin Oncol (R Coll Radiol) (2010) 0.81

Cellular immunity in experimental glomerulonephritis of rats. II. A sequential study of immunological events occurring during development of the disease. Immunology (1973) 0.81

Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M. J Neurosurg (1998) 0.81

Racial and ethnic disparities in the discordance between women's assessment of the timing of their prenatal care entry and the first trimester standard. Matern Child Health J (2001) 0.80

Analysis of a formulation containing lincomycin and spectinomycin by liquid chromatography with pulsed electrochemical detection. J Pharm Biomed Anal (2002) 0.80

Comparison of 51Cr release and microcytotoxicity assays against human melanoma cells. Int J Cancer (1975) 0.80

Cancer survivors' experiences of discharge from hospital follow-up. Eur J Cancer Care (Engl) (2011) 0.80

Delta-1-pyrroline-5-carboxylate and delta-1-pyrroline-3-hydroxy-5-carboxylate: chromatography on the amino acid analyzer. Anal Biochem (1975) 0.80

High dose suppression of human anti-influenza A virus responses using T cell clones. Immunol Cell Biol (1987) 0.80

Hydroxy-L-proline as a substrate for hog kidney D-amino acid oxidase. Biochem Biophys Res Commun (1974) 0.79

The metabolism of hydroxyproline. Mol Cell Biochem (1973) 0.79

Disparities in reported prenatal care advice from health care providers among women of Mexican origin in California. J Immigr Health (2001) 0.79

Papain-induced asthma: a man with dyspnea from dawn till dust. Acta Clin Belg (2013) 0.79

Alanine racemase of Pseudomonas. Observations on subtrate and inhibitor specificity. Arch Biochem Biophys (1974) 0.79

The typing of esterase D in human bloodstains. Med Sci Law (1975) 0.79

Synthesis of peptides and derivatives of 3- and 4- hydroxyproline. Int J Pept Protein Res (1976) 0.78

Quantification of amikacin in bronchial epithelial lining fluid in neonates. Antimicrob Agents Chemother (2011) 0.78

The prediction of dentists' work behaviour; factors affecting choice or intention in the treatment of special need patients. Community Dent Health (1991) 0.78